Skip to main content

Advertisement

Log in

Reply

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kahaly GJ, Rosler HP, Pitz S, Hommel G. Low- versus high dose radiotherapy for Graves’ ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab 2000; 85:102–108.

    CAS  PubMed  Google Scholar 

  2. Mourits MP, Van kempen-Harteveld ML, Garcia Garcia MB, Koppeschaar HPF, Tick L, Terwee CB. Radiotherapy for Graves’ orbitopathy: randomised placebo-controlled study. Lancet 2000; 355:1505–1509.

    Article  CAS  PubMed  Google Scholar 

  3. Marcocci C, Pinchera A, Prummel MF, Wiersinga WM. Immunosuppressive management of Graves’ ophthalmopathy. In: Prummel MF, ed. Recent developments in Graves’ ophthalmopathy. Boston: Kluwer Academic; 2000:101–113.

    Chapter  Google Scholar 

  4. Prummel MF, Mourits MP, Blank L, Bergout A, Koornneef L, Wiersinga WM. Randomised double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy. Lancet 1993; 342:949–954.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. F. Prummel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prummel, M.F. Reply. Eur J Nucl Med 28, 256–257 (2001). https://doi.org/10.1007/s002590000427

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590000427

Keywords

Navigation